Provexis PLC (PXS)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.90p
Buy
1.05p
-0.125p (-11.36%)
Prices updated at 02 Apr 2026, 17:25 BST
| Prices minimum 15 mins delay
Prices in GBX
Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
31 Dec 202530 Oct 202530 Oct 202501 Oct 202530 Sep 202507 Jan 202531 Dec 202431 Dec 202418 Dec 202425 Oct 2024
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Dec 2026 |
| Annual general meeting | Nov 2026 |
| Final results | Oct 2026 |
| Annual report | Oct 2026 |
| Previous date | |
|---|---|
| Half yearly results | Dec 2025 |
| Annual general meeting | Nov 2025 |
| Final results | Oct 2025 |
| Annual report | Oct 2025 |
Company reports
31 Mar 2025
Annual Report 30 Sep 2025
Quarterly Report 